According to the American Autoimmune Related Disease Association(AARDA) approximately 1 in 5 Americans suffer from an autoimmune disease. In fact, Autoimmune Diseases are now ranked as one of the top ten leading causes of death in females under the age of 64 by the AARDA. There have been several studies of the HPV-16L1 antigens, like those used in the Gardasil vaccine, and it has been shown to be plausibly linked to create a cross-reaction of autoimmune diseases.
In a 2009 article in the Journal of Experimental Therapeutics and Oncology, Darja Kanduc of the Department of Biochemistry and Molecular Biology at the University of Bari in Italy, studied the possibility of the HPV vaccine cross-reacting in humans to create an autoimmune adverse reaction. In the end, he stated, “The number of viral matches and their locations make the occurrence of side autoimmune cross-reactions in the human host following HPV16- based vaccination almost unavoidable (Kanduc, 2009*)”. These findings were reaffirmed by Tomlejenovic and Shaw of the Department of Ophthalmology at the University of British Columbia, Canada in 2012, when they studied 2 post-mortem cases following HPV vaccination. “In both cases, the autopsy revealed no anatomical, microbiological nor toxicological findings that might have explained the death of the individuals. In contrast, [their] IHC analysis showed evidence of an autoimmune vasculitis potentially triggered by the cross-reactive HPV-16L1 antibodies binding to the wall of cerebral blood vessels in all examined brain samples… [Their] study suggests that HPV vaccines containing HPV-16L1 antigens pose an inherent risk for triggering potentially fatal autoimmune vasculopathies (Tomlgenovic & Shaw, 2012*)”.
Vaccine induced autoimmune disorders are increasing in the VICP (The National Vaccine Injury Compensation Program). At Krueger and Hernandez, we have clients who have experienced autoimmune triggered disorders such as Postural Orthostatic Tachycardia Syndrome (POTS), autoimmune thyroid disease, and Premature Ovarian Insufficiency (POI) following HPV vaccination. If you or someone you love has experienced an adverse reaction following the administration of the Gardasil vaccine, please contact us. We represent clients from around the country and would be glad to speak with you should you have any questions or concerns about a potential vaccine injury case. Vaccine cases are unlike traditional lawsuits with technical and specialized procedures which are time sensitive, so contact us today. You can contact our Vaccine Lawyers by calling 608-824-9540 or email us at firstname.lastname@example.org . At Krueger Hernandez & Thompson SC, We listen, We care, We get results!
Kanduc, D. (2009). Quantifying the possible cross-reactivity risk of an HPV16 vaccine. Journal of Experiemental Therapeutics and Oncology, 8, 65-76. Retrieved from http://sanevax.org/wp-content/uploads/2011/05/Kanduk-09-HPV-cross-reactivity13.pdf
Tomlgenovic, L., & Shaw, C. A. (2012). Death after Quadrivalent Human Papillomavirus(HPV) Vaccination: Causal or Coincidental? Pharmaceutical Regulatory Affairs: Open Access. doi:10.4172/2167-7689.S12-001
Other Related Blogs:
- How Estate Planning for a Family May Trap the Unwary Practitioner - September 21, 2022
- What Everyone Should Know about the New FDIC Regulations - September 13, 2022
- The Inflation Reduction Act - September 8, 2022